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Global pulmonary and hepatic messenger RNA proﬁles in adult
female C57BL/6 mice intratracheally instilled with carbon
black nanoparticles (NPs) (Printex 90) were analyzed to identify
biological perturbations underlying systemic responses to NP
exposure. Tissue gene expression changes were proﬁled 1, 3, and
28 days following exposure to 0.018, 0.054, and 0.162 mg Printex 90
alongside controls. Pulmonary response was marked by increased
expression of inﬂammatory markers and acute phase response
(APR) genes that persisted to day 28 at the highest exposure dose.
Genes in the 3-hydroxy-3-methylglutaryl-Coenzyme A (HMG-
CoA) reductase pathway were increased, and those involved in
cholesterol efﬂux were decreased at least at the highest dose on days
1 and 3. Hepatic responses mainly consisted of the HMG-CoA
reductase pathway on days 1 (high dose) and 28 (all doses). Protein
analysis in tissues and plasma of 0.162 mg Printex 90–exposed mice
relative to control revealed an increase in plasma serum amyloid A
on days 1 and 28 (p < 0.05), decreases in plasma high-density
lipoprotein on days 3 and 28, an increase in plasma low-density
lipoprotein on day 28 (p < 0.05), and marginal increases in total
hepatic cholesterol on day 28 (p 5 0.06). The observed changes are
linked to APR. Although further research is needed to establish
links between observations and the onset and progression of
systemic disorders, the present study demonstrates the ability of
NPs to induce systemic effects.
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There is a growing number of commercial products
containing nanoparticles (NPs, deﬁned as particles between
1 and 100 nm in at least one dimension), which could lead to
increased occupational exposures. NPs vary signiﬁcantly in
their size, surface area, shape, composition, charge, and surface
chemistry compared with their bulk counterparts. Studies
suggest that NPs readily inﬁltrate deeper pulmonary regions,
are capable of interacting with subcellular structures such as
DNA, and are able to move readily across cellular and tissue
barriers (Vishwakarma et al., 2010). Consequently, some NPs
exhibit increased toxicity in comparison to larger particles.
Upon inhalation, they have been associated with a variety of
adverse biological and physiological responses including
inﬂammation, ﬁbrosis, genotoxicity, and carcinogenicity
(Hubbs et al., 2011).
As inhalation is a primary route of exposure for most NPs,
the pulmonary effects of various nanomaterials have been well
documented. It has also been established that NPs can induce
systemic effects in organs remote from the primary site of
exposure. For example, mice and rats exposed to carbon-based
NPs via inhalation or intratracheal instillation exhibit oxidative
stress, cardiovascular effects, and genotoxicity in various
tissues (Moller et al., 2010) including the systemic microvas-
cular wall (Nurkiewicz et al., 2006) and liver (Jackson et al.,
2012; Nurkiewicz et al.,2 0 0 6 ). One suggested mechanism
for such distal effects is the physical translocation of the NPs
into systemic circulation. However, it is estimated that very
limited amounts of deposited NPs translocate into circulation
(Sadauskas et al., 2009), and systemic effects have been
observed with negligible particle translocation (Jackson et al.,
2012). These distal effects may result from NP-induced
molecular signaling cascades in lung tissue, which in turn
initiate downstream toxic responses in secondary organs. For
example, pulmonary inﬂammation and oxidative stress fol-
lowing NP exposure may result in the release of cytokines,
chemokines, and reactive oxygen species into systemic
circulation. Furthermore, pulmonary exposure to NPs may
activate receptors leading to imbalances in the autonomic
nervous system and the development of cardiac arrhythmia, as
suggested in epidemiological studies of humans exposed to ﬁne
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mechanisms by which NPs may induce systemic effects have
been inferred, the biological processes and the underlying
molecular pathways leading to such systemic toxicities remain
unclear and warrant further investigation.
Carbon black NPs (CBNPs) are poorly soluble spherical
particles of amorphous carbon. CBNPs, including Printex 90
(14 nm CBNP), are the dominating black pigment in printing
inks, paints, and plastics, and large volumes are used as
reinforcing agents in tires and other rubber goods. Concerns
over CBNP safety arose in the mid 1990s, when it was
demonstrated that chronic exposure of rats to carbon black had
the potential to induce tumors similar to those observed with
diesel exhaust particles (presumably via particle overload
mechanisms) (Nikula et al., 1995). Occupational exposure to
CBNPs is associated with decreased lung function (Gardiner
et al., 2001), but it has not been conclusively demonstrated to
be associated with lung cancer (International Agency for
Research on Cancer, 2010). In animal models, chronic and
subchronic exposure to poorly soluble NPs of low toxicity,
including CBNPs, induce mutations (Driscoll et al., 1996) and
lung tumors (Schins and Knaapen, 2007) that are most likely
associated with inﬂammation and oxidative stress. Printex 90
CBNPs have been very well characterized and are used
extensively as a reference material for toxicological evaluations
of NPs. Thus, they are an ideal model for exploring systemic
effects of NP exposure.
We recently demonstrated that exposure to Printex 90
induces sustained pulmonary inﬂammation and persistent
genotoxicity in the lungs and livers of adult female mice
(Bourdon et al., 2012). In the present study, we establish global
pulmonary and hepatic messenger RNA transcriptional proﬁles
using tissues from the same animals. In addition, we quantify
plasma and tissue proteins to determine if exposure to Printex
90 initiates systemic signaling cascades potentially leading to
effects in the liver. This study provides insight into the
molecular events associated with systemic perturbations of
cholesterol homeostasis that are likely associated with CBNP-
induced adverse cardiovascular outcomes.
MATERIALS AND METHODS
Animal handling, exposure, and tissue collection. Animal handling,
exposure and tissue collection have been described previously (Bourdon et al.,
2012). Brieﬂy, female C57BL/6 mice (Taconic, Denmark) were acquired at 5–6
weeks of age and given food (Altromin no 1324; Christian Petersen; Denmark)
and water ad libitum. All procedure complied with EC Directive 86/609/EEC
and Danish laws regulating experiments on animals (permit 2010/561-1179).
Mice were exposed to 0.018, 0.054, and 0.162 mg Printex 90 CBNPs
alongside controls for each postexposure day (1, 3, and 28 days). These doses
equal the pulmonary deposition after 1, 3, and 9 working days for a mouse at
the occupational exposure limit of 3.5 mg/m
3 CB per 8 h work shift (as
established by the Occupational Safety and Health Administration and the
National Institute for Occupational Safety and Health). These calculations
assume that 33.8% of the inhaled mass ends up in the pulmonary region with
a volume of inhaled air per hour of 1.8 l/h and 8 h working days as described in
Jacobsen et al. (2009). The mice did not display any signs of respiratory
distress, decreased locomotor activity, lethargy, or any other physical
symptoms of exposure.
Printex 90 was suspended by sonication in 0.9% NaCl MilliQ water
containing 10% vol/vol acellular bronchial alveolar lavage ﬂuid from C57BL/6
mice. A total of 72 mice (six per group) were given 0.018, 0.054, or 0.162 mg
of Printex 90 CBNPs by single intratracheal instillation. Before the intratracheal
instillation, the mice were anesthetized using Hypnorm (fentanyl citrate 0.315
mg/ml and ﬂuanisone 10 mg/ml from Janssen Pharma) and Dormicum
(midazolam 5 mg/ml from Roche).
The trachea of each mouse was intubated using a 24 gauge BD Incyte catheter
(Becton Dickinson, Denmark) with a shortened needle. The proper location of
the catheter was ensured using a highly sensitive pressure transducer developed
at the National Research Centre for the Working Environment in collaboration
with John Frederiksen (FFE/P, Denmark). A 40 ll suspension was instilled
followed by 150 lla i rw i t ha2 5 0ll SGE glass syringe (250F-LT-GT;
MicroLab, Aarhus, Denmark). Control animals received 40 llv e h i c l e
instillations (0.9% NaCl MilliQ water containing 10% vol/vol acellular
bronchoalveolar lavage [BAL] from C57BL/6 mice). Mice were placed on
a3 7 C heating pad to recover from anesthesia. One, 3, and 28 days after the
instillation, the mice were anesthetized with Hypnorm/Dormicum as described
above. Heart blood (800–1000 ll) was stabilized in 72 ll0 . 1 7 MK 2EDTA and
kept on ice until plasma was isolated by centrifugation at 2000 3 g for 10 min
(4C). BAL ﬂuid, lung, and liver were collected immediately after withdrawing
the heart blood. Tissues were frozen in liquid nitrogen and stored at  80C.
Particle characterization. Printex 90 CBNPs were a gift from Evonik/
Degussa (Frankfurt, Germany). The hydrodynamic particle size distributions in
the exposure media were determined by dynamic light scattering (DLS) using
a Malvern Zetasizer Nano ZS, as described previously (Bourdon et al., 2012).
Agglomeration levels were also assessed by transmission electron microscopy.
DLS analysis of the exposure media was performed on the raw instillation
dispersions and after ﬁltration through 3 lm (Glass Micro Fiber; Whatman,
U.K.) and 0.2 lm (hydrophilic DISMIC-25CS Cellulose Acetate; Toyo Roshi
Kaisha Ltd, Japan) syringe ﬁlters.
Total RNA extraction. Total RNA was isolated from lung and liver tissue
of 72 mice in total (n ¼ 6 mice per group). Isolations were done using TRIzol
reagent (Invitrogen, Canada) and puriﬁed using the RNeasy MiniKit (Qiagen,
Canada). An on-column DNase treatment was applied (Qiagen). RNA
concentrations were determined using a NanoDrop 2000 spectrophotometer
(Thermo Scientiﬁc, Canada). RNA quality was assessed using a BioAnalyzer
(Agilent Technologies, Canada), and only RNA with RNA integrity numbers
above 7.5 was used in the experiment. Total RNA was stored at  80C until
analysis.
Microarray hybridization. Total RNA (200 ng) from each sample (n ¼ 6
per group), alongside Stratagene universal mouse reference RNA (Agilent,
Canada), was used to synthesize double-stranded complementary DNA
(cDNA) and cyanine-labeled complementary RNA (cRNA) using the Agilent
Linear Ampliﬁcation kit (Agilent Technologies). Experimental samples were
labeled with cyanine 5-CTP, whereas reference RNA was labeled with cyanine
3-CTP (PerkinElmer Life Sciences, Canada). The cyanine-labeled cRNA was
in vitro transcribed using T7 polymerase and puriﬁed using RNeasy mini kits
(Qiagen). Sample and reference targets (825 ng) were combined and hybridized
to Agilent 4 x 44K oligonucleotide microarrays (Agilent Technologies) for 17 h
at 60C. The arrays were washed according to supplier instructions and then
scanned on an Agilent G2505B scanner at 5 lm resolution. Data were acquired
using Agilent Feature Extraction software version 9.5.3.1.
Statistical analysis of microarray data. A reference design was employed
to determine global differential gene expression, and randomized blocks were
used to offset interarray effects. Median signal intensities were normalized
using LOWESS in R, and differential gene expression was determined using
the microarray analysis of variance (MAANOVA) library (R Development
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determine gene-speciﬁc treatment effects, and the associated p values were
estimated using the permutation method (30,000 permutations with residual
shufﬂing). Data were adjusted for multiple comparisons using the Benjamini
and Hochberg false discovery rate (FDR) approach to limit false-positive
results. Fold changes were based on least square means of each pairwise
comparison. p values and fold changes for probes of the same target were
averaged. Genes having an FDR-adjusted p < 0.1 and a fold change > 1.5 were
deemed differentially expressed.
Data quality was evaluated in GeneSpring GX version 11.5.1 (Agilent
Technologies). Dye bias was determined by generating MA plots and scatter
plots. Outliers were identiﬁed using hierarchal clustering and box plots. Mining
of the pathways and processes represented among the signiﬁcant genes was
conducted in Ingenuity Pathway Analysis version 8.6. A right-tailed Fisher’s
exact test was used to calculate p values for each biological pathway. DAVID
Bioinformatics Resources 6.7 was used to identify enriched biological
functions from terms with similar genes and biological meaning (Huang
et al., 2009a,b). Biological functions with enrichment scores > 1.3 were
considered signiﬁcant, in accordance with DAVID recommendations (Huang
et al., 2009b).
Real-time PCR. Primers were designed within the same exon as the
Agilent microarray probe sequence using Beacon Designer 2.0 (Premier
BioSoft International, USA). Primer speciﬁcity was assured by melting curve
analysis, and optimal annealing temperatures were determined by gradient PCR
experiments. Total RNA (1 lg) from lung and liver was reverse transcribed to
cDNA for each sample (n ¼ 4 per group), using the SuperScript III First-Strand
Synthesis system (Invitrogen). Real-time quantitative PCR was performed on
10-fold cDNA dilutions in duplicate using a CFX96 real-time PCR detection
system (Bio-Rad, Canada). Threshold cycle values were averaged. PCR
efﬁciency for both the gene of interest and the reference gene was extrapolated
from a standard curve, established by a ﬁvefold serial dilution of pooled cDNA.
Fold changes were calculated according to the 2
 nnCT method, using the CFX
manager software (Bio-Rad). Statistical inference was established using the
REST program version 2.0.13 (Pfafﬂ et al., 2002).
PCR arrays. PCR arrays were employed for analysis of transcripts
involved in inﬂammatory responses, oxidative stress, and cholesterol efﬂux in
lung. The complete list of genes and the results obtained for PCR arrays can be
found in Supplementary table 3. Total RNA (1 lg) from lung was reverse
transcribed into cDNA using an RT
2 First Strand Kit (SABiosciences, USA).
RT
2 SYBR Green PCR master mix was employed for real-time PCR, and
experiments were carried out using a CFX96 real-time PCR detection system
(Bio-Rad). Threshold cycles were averaged.
Using the delta CT values, differentially expressed genes were identiﬁed
using a two-sample bootstrap test (t-pivot method) assuming unequal variances
using the R software (Higgins, 2003). Standard errors for the fold change for
each comparison were estimated using the bootstrap method.
Total lipid extraction and total hepatic cholesterol analysis. Total lipids
were extracted from liver tissue according to the Folch method. Brieﬂy, liver
tissue was homogenized in 500 ll equal volumes of methanol and water.
A double volume of 5:1 chloroform/methanol was then added, and phases were
separated by centrifugation. The lower chloroform lipid–containing layer was
separated, and chloroform removed under nitrogen gas ﬂow. Lipids were
resuspended in 100 ll EnzyChrom assay buffer and stored at  20C until
analysis.
The EnzyChrom AF Cholesterol Assay Kit (BioAssay Systems, USA) was
employed for quantitative colorimetric determination of hepatic cholesterol
levels (n ¼ 6 per group; 0.162 mg dose group and controls), according to
manufacturer recommendations. Brieﬂy, lipid extracts from each sample and
a serial dilution of a standard cholesterol reference supplied by the
manufacturer were diluted 10-fold, and 50 ll aliquots were placed in a clear
96-well plate, in duplicate. Fifty microliter of a dye reagent-enzyme mix was
added, and the plate was incubated at room temperature for 30 min. The color
intensity of the reaction product was spectrophotometrically measured at 570
nm, and total cholesterol concentrations were determined by comparison to the
standard curve, with normalization to extracted tissue weight. Statistical
signiﬁcance was determined using an unpaired one-tailed t-test assuming
unequal variances.
Plasma high-density lipoprotein, low-density lipoprotein/very low-density
lipoprotein, and total cholesterol analysis. Fluorimetric quantiﬁcation of
cholesterol was determined in plasma using the EnzyChrom AF HDL and
LDL/VLDL assay kit (BioAssay Systems) according to the manufacturer’s
instructions (n ¼ 6 per group; 0.162 mg dose group and controls). HDL
isolation was performed by collection of the supernatant following
centrifugation of a 1:1 plasma-precipitating reagent solution. The low-
density lipoprotein/very low-density lipoprotein (LDL/VLDL) fraction was
separated by dissolution of the collected pellet in PBS. Plasma, high-density
lipoprotein (HDL), and LDL/VLDL isolations from each sample and a serial
dilution of a standard cholesterol reference supplied by the manufacturer
were diluted 10-fold, and 50 ll aliquots were placed in a clear 96-well plate,
in duplicate. Fifty microliter of a dye reagent-enzyme mix was added, and the
plate was incubated at room temperature for 30 min. Fluorescence
measurements were recorded on a SpectraMax M2 (Molecular Devices,
USA) at 530 nm (excitation) and 585 nm (emission), and cholesterol
concentrations were determined by comparison to a standard curve.
Statistical inference was determined using an unpaired one-tailed t-test
assuming unequal variances.
Plasma serum amyloid A analysis. Total serum amyloid A (SAA) was
measured in plasma samples using the PhaseRange Mouse SAA ELISA kit
(Tridelta Development Ltd, Ireland), according to manufacturer’s instructions
(n ¼ 6 per group; 0.162 mg dose group and controls). Brieﬂy, plasma from
each mouse and a serial dilution of a standard SAA reference supplied by the
manufacturer were diluted 200-fold and mixed with an equal volume of anti-
SAA horseradish peroxidase (HRP) conjugate. One hundred microliter of each
plasma-antibody solution was loaded in duplicate in a 96-well plate precoated
with SAA antibody, incubated for 1 h at 37C and subjected to four wash
cycles. A streptavidin-HRP enzyme was then added to each well and incubated
for 15 min at room temperature. The reaction was quenched by the addition of
100 ll of stop solution. Absorbance measurements were read at 450 nm with
a SpectraMax M2 (Molecular Devices, USA), and SAA concentrations were
determined by comparison to the standard curve. Statistical inference was
determined by unpaired one-tailed t-test, assuming unequal variances.
RESULTS
Particle Characterization
Printex 90 CBNPs have been characterized extensively in
Bourdon et al. (2012). A summary of this particle character-
ization can be found in Table 1. Brieﬂy, the manufacturer
declares a primary particle size of 14 nm. The reported
polycyclic aromatic hydrocarbon and endotoxin content
reported in Table 1 are not expected to cause biological
effects, as described thoroughly in Bourdon et al. (2012);
Jacobsen et al. (2007, 2008). CBNPs within instillation vehicle
displayed a high degree of agglomeration, which is in
accordance with the low zeta potential reported. DLS analysis
of the raw instillation vehicle revealed that the suspension was
highly polydisperse, with a peak size of approximately 2.6 lm.
Size distribution of these agglomerates was broad, ranging
from less than 100 nm but typically 200 nm or larger. The
largest of the agglomerates were in the range of 20–30 lm.
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polydispersity index observed. Filtering (3.1 and 0.2 lm) of the
raw dispersion vehicle revealed the presence of smaller
particles.
Inﬂammatory Cell Inﬂux in BAL
The animals used in this study were from a previous
experiment. Details of this study can be found in Bourdon et al.
(2012). Brieﬂy, characterization of the cell composition of
BAL revealed elevated total BAL cell counts 1 and 3 days
postexposure for all doses (0.018, 0.054, and 0.162 mg) and
sustained increases for the medium and high doses up to the
28-day time point. This response was primarily dominated by
increases in neutrophils at all doses and time points studied.
Eosinophils and lymphocytes were also increased at all doses
but only at the 3-day time point. BAL cell counts for
neutrophils, eosinophils, macrophages, lymphocytes, and total
BAL cells are presented in Supplementary ﬁgures 1A–E.
Global Pulmonary Differential Gene Expression
Gene expression microarray analysis was conducted on the
left lung lobe (whole tissue) from a total of 72 mice (n ¼ 6 per
treatment group) exposed to vehicle (control), 0.018, 0.054,
and 0.162 mg of Printex 90 CBNPs by a single intratracheal
instillation and necropsied 1, 3, and 28 days postexposure. MA
plots, box plots, and cluster analyses of normalized signal
intensities for all probes revealed that 5 of 72 microarrays
produced substandard data quality (data not shown). These
arrays were distributed across treatment conditions and were
removed from the analysis. The MAANOVA analysis was thus
conducted on a ﬁnal sample size of at least ﬁve mice per
treatment group to identify differentially expressed genes.
Genes with FDR-adjusted p < 0.1 and fold changes > 1.5 in
either direction were considered differentially expressed.
MAANOVA analysis revealed that 487 genes were
signiﬁcantly differentially expressed (upregulated or down-
regulated relative to control samples) in at least one of the
treatment conditions. The complete list is presented in
Supplementary table 1A. There were 2, 45, and 294
differentially expressed genes 1 day postexposure and 0, 11,
and 201 differentially expressed genes 3 days postexposure in
the 0.018, 0.054, and 0.162 mg dose groups, respectively. At
28 days postexposure, the high-dose group showed 123 altered
genes, but no effects were observed for the two lower doses.
Thus, the low-dose treatment groups had very little effect on
the global expression proﬁles as measured on DNA micro-
arrays. The number of genes that were in common between the
0.162 mg dose across time points is shown in a Venn diagram
in Supplementary ﬁgure 2A. Cluster analysis revealed dose-
response trends within time points with similar pathways/
functions affected at the high dose and the lower doses. The
results demonstrate substantial changes over time in the subset
of genes differentially affected by the Printex 90 exposure
(evident within the 0.054 and 0.162 mg doses only as shown
by heat maps in Supplementary figs. 2B and C). The complete
microarray dataset is available through the Gene Expression
Omnibus at NCBI (http://www.ncbi.nlm.nih.gov/geo/, Supers-
eries GSE35284, SubSeries GSE35193).
Data mining using DAVID functional annotation clustering
to determine functional groups of similar genes and affected
biological processes revealed 40 annotations with enrichment
scores > 1.3 (Supplementary table 2A). These biological
functions were mostly related to inﬂammatory, immune, and
acute phase responses (APRs) but also included changes in
sterol biosynthesis, apoptosis signaling, and cell cycle
regulation. Ingenuity pathway analysis of the high-dose group
revealed the predominance of inﬂammatory and immune
responses across all time points (Supplementary fig. 2D).
Transcript changes for genes involved in inﬂammation
(29 genes), cholesterol transport (2 genes), oxidative stress,
and antioxidant responses (8 genes) were validated using PCR
arrays and showed a high correlation with the DNA microarray
results (Supplementary table 3A).
Global Hepatic Differential Gene Expression
Because major persistent effects were only observed in the
lungs at the highest doses, hepatic microarray gene expression
proﬁling was only conducted on mice exposed to 0.162 mg
CBNPs and sacriﬁced 1, 3, and 28 days postexposure. Six
outliers were removed from the analysis based on quality
control metrics (MA plots, box plots, and cluster analysis of
normalized signal intensities for reference RNA and biological
samples). MAANOVA analysis was conducted on a ﬁnal
sample number of at least four per treatment group to identify
differentially expressed genes. Genes with FDR-adjusted
TABLE 1
Physical-Chemical Properties of Printex 90 as a Raw Material
and in Vehicle (0.9% NaCl MilliQ Water Containing 10% vol/vol
Acellular BAL)
Particle characterization
Manufacturer declared size (nm) 14
Surface area (BET) (m
2/g) 295–338
Pycnometric particle density (g/cm
3) 2.1
Chemical composition 99% C, 0.8% N,
and 0.01% H2
Polycyclic aromatic hydrocarbon (ng/g) 74.2
Endotoxin (EU/g) 142
Particle properties in vehicle
Polydispersity index 1
Zeta potential (mV)  10.7
Peak hydrodynamic number (lm) 2.6
Peak volume-size distribution (lm) 3.1
Morphology Free and open chain
aggregates with minor
amounts of free single
primary spheres
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considered signiﬁcant (differentially expressed) and were
analyzed in detail. The analysis revealed 81 differentially
expressed genes (upregulated and downregulated) overall
(Supplementary table 1B). Within time points, 53, 2, and 26
changes in transcripts were found on days 1, 3, and 28,
respectively. None of the genes identiﬁed overlapped across
time points as shown in the Venn diagram in Supplementary
figure 1E. Cluster analysis revealed clear exposure effects on
d a y1a n dd a y2 8b u tn o to nd a y3a ss h o w ni nt h eh e a tm a pi n
Supplementary figure 2F. Microarray data are available through
the Gene Expression Omnibus at NCBI (http://www.ncbi.nlm.
nih.gov/geo/, SuperSeries GSE35284, SubSeries 35192).
DAVID functional annotation clustering revealed four
biological functions with an enrichment score > 1.3
(Supplementary table 2B). These clusters were related to
sterol and terpenoid biosynthesis, cytochrome p450 and cell
movement. Ingenuity pathway analysis of biological func-
tions across time points also revealed lipid metabolism as the
primary process perturbed in liver by Printex 90 exposure
(Supplementary fig. 2G).
Inﬂammation and APR Signaling in Lung, Liver, and Plasma
Mining of lung microarray data by Ingenuity pathway
analysis showed that approximately 38% of the differentially
expressed genes were directly associated with inﬂammatory
responses. In the high-dose groups, upregulated expression of
several of these genes, including chemokine (C-C motif)
ligands 2 (Ccl2), Ccl3, Ccl8, Ccl9, and Ccl12 was evident on
day 1 and persisted up to 28 days postexposure, with fold
changes ranging from 1.5- to 5.0-fold above control animals.
Twenty-nine genes involved in inﬂammation were validated
using PCR arrays and correlated highly with the DNA
microarray results (Supplementary table 3A).
The highest fold changes in the lungs of mice intratracheally
instilled with CBNPs were attributed to SAA genes (Saa1,
Saa2, and Saa3) and other genes involved in APR signaling,
including metallothioneins and orosomucoids (Table 2).
Quantitative real-time PCR analysis in lung revealed that
Saa1 and Saa3 were also affected at lower doses of exposure
(i.e., all doses on postexposure day 3) and at later time points
(i.e., the 0.162 mg dose on postexposure day 28) (Supplemen-
tary table 3B). Our results correlate strongly with previous
measurements of Saa3 in the same tissue (Bourdon et al.,
2012). However, we could not validate the upregulation of
Saa3 in liver by quantitative real-time PCR (Bourdon et al.,
2012).
To conﬁrm the presence of SAA protein, we measured total
SAA levels in plasma of an additional set of mice exposed to
0.162 mg CBNPs using identical exposure procedures. Total
SAA levels were increased by 15.3% on postexposure day 1
(from 1.2 to 1.4 mg/dl; p < 0.05), by 15.6% on day 3 (from 1.1
to 1.3 mg/dl; p ¼ 0.0789), and by 11.8% on day 28 (from 1.0
to 1.1 mg.dl; p < 0.05) (Fig. 1A).
Alterations in Cholesterol Homeostasis
Pulmonary and hepatic gene expression proﬁling in parallel
with plasma analysis strongly suggested systemic alterations in
TABLE 2
Expression Over Control of Acute Phase Response Signaling Genes Measured by Agilent 4 x 44K Microarray Analysis in C57BL/6
Mice Exposed to 0.162 Printex 90 CBNPs and Sacriﬁced 1, 3, and 28 Days Postexposure. Fold Changes Over Matched Controls and
p Value Are Presented
Day 1 Day 3 Day 28
Gene name Fold change p Value Fold change p Value Fold change p Value
Lung
Serum amyloid A3 (Saa3) 65.3 0.00 8.3 0.00 6.8 0.00
Metallothionein 2 (Mt2) 5.7 0.00 2.1 0.00 1.3 0.30
Ceruloplasmin (Cp) 3.5 0.00 2.2 0.00 1.1 0.55
Metallothionein 1 (Mt1) 2.1 0.00 1.7 0.00 1.2 0.06
Serum amyloid A1 (Saa1) 11.3 0.00 1.7 0.02 1.5 0.07
Serum amyloid A2 (Saa2) 6.9 0.00 1.4 0.11 1.3 0.23
Orosomucoid 2 (Orm2) 3.6 0.00 1.3 0.19 1.4 0.12
Orosomucoid 1 (Orm1) 2.6 0.00 1.1 0.42 1.2 0.15
Complement component 3 (C3) 2.0 0.00 1.4 0.00 1.5 0.01
Liver
Serum amyloid A3 (Saa3) 4.2 0.00 1.0 0.91 0.5 0.96
Orosomucoid 3 (Orm3) 2.2 0.02 0.5 0.98 1.0 0.92
Serum amyloid A1 (Saa1) 1.5 0.03 0.6 0.77 0.6 0.27
C-reactive protein (Crp) 1.0 0.92 1.5 0.10 1.7 0.03
Note. Data in bold are FDR signiﬁcant (< 0.1).
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the high-dose group revealed signiﬁcant upregulation of genes
involved in cholesterol synthesis, on postexposure days 1 and 3
relative to control mice (Table 3). DAVID functional
annotation clustering revealed this subset of genes to be
involved directly in sterol and terpenoid biosynthesis (enrich-
ment score ¼ 3.4) (Supplementary table 2A). These biological
functions collectively form the 3-hydroxy-3-methylglutaryl-
Coenzyme A (HMG-CoA) reductase pathway, which is the
rate-limiting pathway of cholesterol synthesis. Two genes of
this pathway (Sqle and Fdps) were conﬁrmed by quantitative
real-time PCR in lung (Supplementary table 3B).
Microarray analysis of pulmonary proﬁles also demonstrated
substantial downregulation of cholesterol efﬂux gene ATP-
binding cassette subfamily G member 1 (Abcg1,  1.7-fold) at
the highest exposure dose on day 1. Quantitative real-time PCR
of Abcg1 and associated ATP-binding cassette subfamily
A member 1 (Abca1) showed 2.3- and 2.6-fold downregulation
of Abcg1 and Abca1 on day 1, and 1.8-fold downregulation of
Abcg1 on day 3 (Supplementary table 3A).
Substantial upregulation of the HMG-CoA reductase pathway
was also found in liver, as demonstrated by the highly enriched
sterol and terpenoid biosynthesis cluster using DAVID
functional annotation clustering (enrichment score ¼ 7.7)
(Supplementary table 2B). The pathway was perturbed on
postexposure day 1 in the high-dose mice, relative to controls.
Expression changes were fairly consistent across these genes,
ranging from a 1.6- to a 2.6-fold increase in treated over control
mice (Table 3). In order to clarify whether the HMG-CoA
reductase pathway activity is also affected at later time points
and lower doses of exposure, we measured Hmgcr, Dhcr7,
Fdps, Mvd, and Sqle transcript levels using quantitative real-
time PCR. Our microarray ﬁndings were conﬁrmed for
postexposure day 1. However, many genes were also found
to be differentially expressed on day 28 at all exposure doses
(Supplementary table 3B).
In order to substantiate changes in cholesterol synthesis, we
measured cholesterol levels in plasma and livers of the mice.
Plasma analysis in the additional mice exposed according to the
same exposure regimen (high dose and controls only) revealed
FIG. 1. Changes in (A) plasma total SAA, (B) plasma HDL, (C) plasma LDL, and (D) hepatic total cholesterol in C57BL/6 mice exposed to vehicle and 0.162 mg
Printex 90 CBNPs and sacriﬁced 1, 3, and 28 days postexposure. Signiﬁcance was calculated by comparison to matched control, and * indicates p < 0.05.
SYSTEMIC EFFECTS OF NANOPARTICLE EXPOSURE 479no effects of CBNP exposure on total plasma cholesterol (data
not shown). However, HDL levels were decreased on
postexposure days 3 and 28 (p < 0.05) by 21.8 and 25.7%
(Fig. 1B). LDL levels were also increased by 18.8% on
postexposure day 28 (Fig. 1C). Total cholesterol levels in
hepatic tissues were marginally elevated in the 0.162 mg
exposed mice groups on day 28 (p ¼ 0.06) compared with
sham controls. Overall, total hepatic cholesterol was increased
by 22.2, 12.1, and 22.6% in the high-dose group on days 1, 3,
and 28, respectively (Fig. 1D). We note that our cholesterol
analyses resulted in some variability between postexposure day
controls. The reason for this effect is unknown but may be
related to the intratracheal instillation procedure.
DISCUSSION
We investigated pulmonary and hepatic gene expression in
mice instilled with vehicle, 0.018, 0.054, and 0.162 mg Printex
90 CBNPs and sacriﬁced 1, 3, and 28 days after this single
exposure. Gene expression proﬁles in lungs revealed large-
scale CBNP-induced perturbations of inﬂammatory cytokine
and chemokine transcripts, supported by concomitant changes
in BAL cell counts. Large changes in acute phase SAA
transcripts (Saa1, Saa2, and Saa3) were measured in the lungs
up to 28 days postexposure for the highest dose group and up
to 3 days postexposure in the lower dose groups relative to
controls. Elevated SAA protein was conﬁrmed in the plasma of
mice exposed to 0.162 mg Printex 90 on postexposure days 1
and 28. Genes in the HMG-CoA reductase pathway were
perturbed in both lung and liver. In the lung, these changes
were observed at the two higher doses on postexposure days 1
and 3, whereas more substantial changes in liver were detected
on days 1 (0.162 mg dose) and 28 (all doses). In parallel, HDL
cholesterol was decreased relative to controls 3 and 28 days
postexposure, whereas LDL cholesterol was increased at 28
days (i.e., 0.162 mg dose group). Thus, our genomic proﬁling
demonstrates the cascade of events initiated through in-
ﬂammation and APR in the lungs leading to liver transcrip-
tional changes and impacting lipid homeostasis following NP
exposure.
Inhalation of CBNPs can cause direct pulmonary injury, thus
instigating an inﬂammatory response. Indeed, the inﬂammatory
response was the overwhelming biological effect observed in
our transcript proﬁles, supporting the observed phenotype. The
proinﬂammatory genes identiﬁed were primarily involved in
recruitment and activation of various inﬂammatory markers
including neutrophils (Cxcl5, Ccl3, and Cxcl1), eosinophils,
(Ccl11, Ccl12, and Ccl8), monocytes (Ccl7, Ccl2, Ccl4, Cc12,
and Ccl8), and lymphocytes (Ccl20, Ccl24, and Ccl12) with
large persisting increases in Cxcl5 that may explain the
predominance of neutrophils in our BAL cell proﬁles (Bourdon
et al., 2012).
Inﬂammatory signaling molecules, including interleukin-6
and tumor necrosis factor (both upregulated by CBNP
exposure), have been suggested to trigger the APR. APR is
characterized by rapid induction of positive acute phase
proteins (e.g., c-reactive protein, SAA, and serum amyloid P),
decreases in negative acute phase proteins (e.g., albumin and
transferrin), and physiological changes (e.g., altered metabolism
TABLE 3
Expression of Genes Part of the HMG-CoA Reductase Pathway Measured by Agilent 4 x 44K Microarray Analysis in C57BL/6 Mice
Exposed to 0.162 Printex 90 CBNPs and Sacriﬁced 1, 3, and 28 Days Postexposure. Fold Changes Over Matched Controls and p Value
Are Presented
Day 1 Day 3 Day 28
Gene name Fold change p Value Fold change p Value Fold change p Value
Lung
Squalene epoxidase (Sqle) 1.6 0.00 1.8 0.00 1.2 0.04
Isopentyl-diphosphate delta isomerase (Idi) 1.4 0.00 1.7 0.00 1.2 0.11
Farnesyl-diphosphate synthase (Fdps) 1.3 0.02 1.6 0.00 1.3 0.02
Diphosphomevalonate decarboxylase (Mvd) 1.4 0.01 1.5 0.00 1.3 0.03
Liver
3-Hydroxy-3-methylglutaryl-CoA reductase (Hmgcr) 2.8 0.00 0.5 0.67 2.4 0.00
Lanosterol synthase (Lss) 2.6 0.00 1.2 0.34 1.3 0.08
Isopentyl-diphosphate delta isomerase (Idi) 2.3 0.00 1.2 0.10 1.5 0.03
HMG-CoA synthase (Hmgcs1) 2.0 0.00 1.2 0.28 1.4 0.13
Squalene epoxidase (Sqle) 1.9 0.00 1.2 0.33 1.2 0.25
Mevalonate kinase (Mvk) 1.9 0.00 1.2 0.12 1.2 0.12
Farnesyl-diphosphate synthase (Fdps) 1.8 0.00 1.1 0.30 1.2 0.08
7-Dehydrocholesterol reductase (Dhcr7) 1.6 0.00 1.1 0.48 1.2 0.24
Diphosphomevalonate decarboxylase (Mvd) 1.9 0.00 0.5 0.79 1.1 0.98
Note. Data in bold are FDR signiﬁcant (< 0.1).
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to prevent further injury and to activate repair processes.
Prolonged APR is linked to aortic inﬂammation and acceler-
ated atherosclerosis, as observed in individuals with chronic
inﬂammatory diseases including rheumatoid arthritis and
systemic lupus erythematosus (Hollan et al., 2007). It has also
been shown that increased levels of SAA in plasma directly
accelerate progression of atherosclerosis in ApoE
 /  mice
(Dong et al.,2 0 1 1 ). For such reasons, positive acute phase
proteins (e.g., c-reactive protein, phospholipase A2, and
SAA) are proposed biomarkers of potential cardiovascular
disease (Ballantyne et al.,2 0 0 4 ). Inhalation of nano-sized
nickel and titanium dioxide has been shown to initiate an
APR in mouse (Halappanavar et al.,2 0 1 1 ; Kang et al.,2 0 1 1 ).
Here, we demonstrate that a single installation of relatively
low doses of CBNPs induces inﬂammation with an associated
APR that can persist for 28 days. As such, we speculate that
exposure to CBNPs and possibly other nanoparticulates may
be associated with chronic inﬂammation-mediated APR,
which in turn may increase susceptibility to cardiovascular
disease.
One of the mechanisms by which inﬂammation-triggered
APR may elicit adverse cardiovascular outcomes is through
interruption of cholesterol transport (Feingold and Grunfeld,
2010). APR is implicated in disrupting reverse cholesterol
transport at many levels, including reduced levels and altered
functions of HDL, as well as reduced efﬁcacy of cholesterol
efﬂux and bile acid synthesis. HDL, which facilitates reverse
cholesterol transport and inhibits the oxidation of LDL in
healthy individuals, is greatly reduced in humans (Annema
et al., 2010) and in mice (McGillicuddy et al., 2009) during the
APR and in our study. Increased plasma levels of SAA
observed in our study may lead to interruption of reverse
cholesterol transport by displacement of apolipoproteins and
replacement of cholesterol esters and phospholipids by
triglycerides, unesteriﬁed cholesterol, and ceramides (Feingold
and Grunfeld, 2010). Such modiﬁcations in HDL are suggested
to inhibit both cholesterol efﬂux from macrophages and
protection against LDL oxidation (Annema et al., 2010;
Feingold and Grunfeld, 2010; McGillicuddy et al., 2009).
These alterations may even allow HDL to participate in
inﬂammatory responses and to deliver cholesterol to macro-
phages (Feingold and Grunfeld, 2010). In addition, APR also
affects lipid transport by downregulating cholesterol efﬂux
genes in peripheral tissues and by reducing hepatic cholesterol
uptake and synthesis of bile acids (McGillicuddy et al., 2009).
Although we did not detect any alterations in hepatic
cholesterol uptake or bile synthesis, we observed down-
regulation of cholesterol efﬂux genes Abca1 and Abcg1 in
pulmonary tissue. Our results suggest that a single instillation
of Printex 90 leads to inﬂammation and APR, which markedly
alters systemic cholesterol transport and metabolism over
a prolonged time scale. These processes can lead to adverse
health outcomes when induced chronically.
Alterations in lipid transport (such as those described above)
can trigger sterol-sensitive pathways in extra-pulmonary tissues.
As a central site of metabolism, the liver plays an important role
in regulating lipid homeostasis. The mice in the present study
exhibited signiﬁcant changes in hepatic expression of Hmgcr,
which is rate limiting in the HMG-CoA reductase pathway and in
de novo cholesterol production. HMG-CoA is exclusively
activated under low-sterol conditions in a negative feedback
loop and fulﬁlls two important biological functions: (1) pro-
duction of terpenoid intermediates to serve in the prenylation of
small GTPases (e.g., Ras, Rac, and Rho) and activation of
a variety of cellular processes (e.g., actin cytoskeleton remodel-
ing, cellular proliferation, generation of reactive oxygen species,
and inﬂammatory responses) (Liao, 2002) and (2) cholesterol
production. Exposure to CBNP in the present study caused
a fairly uniform upregulation of genes across this entire pathway
(Hmgcr, Mvd, Fdps, Sqle,a n dDhcr7). Upregulation of genes
downstream of Sqle suggests that CBNP exposure tips this
pathway toward cholesterol production. Cholesterol is critical
for maintaining cellular membrane integrity (e.g., lipid rafts,
signal transduction, and molecular exchanges). It has been
established that severe inﬂammation, infection, and APR activate
the HMG-CoA reductase pathway in the liver of rodents, as
demonstrated in models of lipopolysaccharide treatment
(Feingold et al., 1993, 1995; Memon et al., 1993). Here, we
demonstrate that Printex 90 intratracheal instillation leads to
upregulation of the HMG-CoA reductase pathway in liver and
lung, with concomitant ‘‘modest’’ changes in plasma LDL and
marginal increases in hepatic cholesterol. The results suggest that
pulmonary CBNP responses trigger molecular signaling cascades
affecting the liver, and that these responses may drive excess
production of cholesterol. It is possible that perturbations of
cholesterol homeostasis observed in our work may be further
exacerbated by the protein corona created around CBNPs.
A recent study using N-isopropylacrylamide and N-t-butylacry-
lamide copolymers of varying size and composition demonstrates
that NPs bind cholesterol, triglycerides, and phospholipids (with
preference to HDL) and that binding reaches saturation
(Hellstrand et al., 2009). This effect is strongest with increased
hydrophobicity and surface area of the particle and thus relevant
to the chemical properties of Printex 90 CBNPs. Therefore, this
may be an additional mechanism by which the HMG-CoA
reductase pathway is upregulated in the present study.
Exposure to ﬁne and ultraﬁne particles is associated with
increased incidences of cardiovascular events and long-term
risk of heart disease (Pope et al., 2004). Prominent
mechanisms of particle-induced cardiovascular disease
include alterations in the autonomic nervous system resulting
in cardiac arrhythmia, chronic systemic oxidative stress, and
inﬂammation leading to atherosclerotic plaque formation,
endothelial dysfunction, and APR-induced thrombosis
(Brook, 2008). Here, we propose that NP-induced APR
triggers changes in lipid transport and metabolism, thus
activating the atherogenic HMG-CoA reductase pathway
SYSTEMIC EFFECTS OF NANOPARTICLE EXPOSURE 481(Fig. 2). The implication of the HMG-CoA reductase pathway
in cardiovascular disease extends beyond excess cholesterol
synthesis to endothelial nitric oxide expression and activa-
tion-mediated endothelial dysfunction (Rikitake and Liao,
2005), systemic oxidative stress–induced oxidation of LDL
and activation of macrophages (Ilker-Yilmaz et al.,2 0 0 3 ),
and release of proinﬂammatory factors that participate in
leukocyte adhesion and progression of atherosclerotic lesions
(Yoshida, 2003). In parallel, it has been suggested that HMG-
CoA reductase inhibitors (i.e., statins) may be effective in
preventing ambient particulate matter–induced coronary
artery disease in individuals with elevated c-reactive protein
levels, regardless of lipid proﬁles (Sandhu et al.,2 0 0 5 ).
Further investigations are required to decipher the role of NPs
in the disruption of cholesterol synthesis and metabolism and
possible implications to metabolic and cardiovascular disease.
At this time, it is unclear whether intratracheal instillations of
NPs are expected to induce more substantive effects than
exposure by inhalation. Although intratracheal instillation of
P r i n t e x9 0C B N P sh a sb e e ns h o w nt oc a u s em o r e
i n ﬂ a m m a t i o ni nt e r m so fn e u t r o p h i li n ﬂ u xi nc o m p a r i s o nt o
inhalation of the same dose (Jackson et al.,f o r t h c o m i n g ;
Jacobsen et al., 2009), it has been shown that daily inhalation
exposure to nano-titanium dioxide over 11 days and at doses
well below the current occupational exposure limit resulted in
pulmonary APR that persisted at least 5 days after the last
exposure (Halappanavar et al., 2011). This study is the ﬁrst
to simultaneously assess global lung and liver gene expres-
sion responses to CBNPs across various doses and extended
to late time points to explore sustained molecular effects.
The results provide important insights into NP-mediated
systemic changes in APR, inﬂammation, and cholesterol
homeostasis. The data indicate the power of a global systems
biology approach to identify perturbed processes and
identify candidate biological pathways supporting observed
phenotypes.
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